Superficial curettage + imiquimod 5% cream for nodular BCC shows promising results, potentially noninferior to surgical excision after 5 years. #SkinCareResearch PMID:39878970, JAMA Dermatol 2025 https://doi.org/10.1001/jamadermatol.2024.5572 🧪
March 2, 2025 at 11:10 AM
Superficial curettage + imiquimod 5% cream for nodular BCC shows promising results, potentially noninferior to surgical excision after 5 years. #SkinCareResearch PMID:39878970, JAMA Dermatol 2025 https://doi.org/10.1001/jamadermatol.2024.5572 🧪
K-beauty brands love claiming 'clinically proven' but won't share who was actually in that clinic. Fitzpatrick I–III only, and their data looks 'complete.' Tell me why I should trust a trial my skin type didn't qualify for. #SkincareScienceMatters #SkincareResearch
August 28, 2026 at 1:15 PM
K-beauty brands love claiming 'clinically proven' but won't share who was actually in that clinic. Fitzpatrick I–III only, and their data looks 'complete.' Tell me why I should trust a trial my skin type didn't qualify for. #SkincareScienceMatters #SkincareResearch
New bioactive compounds are transforming skincare by addressing aging, skin cancer prevention & hair loss through FDA-approved clinical trials. # skincareevolution #beautyinnovation #skincareresearch 🧬💅 Cheap Makeup with Discount: cutt.ly/frRsl4b2
June 27, 2025 at 12:16 AM
New bioactive compounds are transforming skincare by addressing aging, skin cancer prevention & hair loss through FDA-approved clinical trials. # skincareevolution #beautyinnovation #skincareresearch 🧬💅 Cheap Makeup with Discount: cutt.ly/frRsl4b2
www.linkedin.com/pulse/dermat...
Dermata’s Xyngari(TM) Set to Transform Acne Treatment with FDA Approval
kstrategyand.com/pharma-news
#DermataTherapeutics #Xyngari #FDAApproval #AcneTreatment #BiotechInnovation #Phase3ClinicalTrial #SkincareResearch #Humanteconomy #Humantec #KStrategyand
Dermata’s Xyngari(TM) Set to Transform Acne Treatment with FDA Approval
kstrategyand.com/pharma-news
#DermataTherapeutics #Xyngari #FDAApproval #AcneTreatment #BiotechInnovation #Phase3ClinicalTrial #SkincareResearch #Humanteconomy #Humantec #KStrategyand
Dermata’s Xyngari(TM) Set to Transform Acne Treatment with FDA Approval
Dermata Therapeutics has received FDA approval for the proprietary name "Xyngari" (formerly DMT310), a significant milestone for the biotechnology company. Xyngari is a cutting-edge product currently ...
www.linkedin.com
January 9, 2025 at 10:17 AM
www.linkedin.com/pulse/dermat...
Dermata’s Xyngari(TM) Set to Transform Acne Treatment with FDA Approval
kstrategyand.com/pharma-news
#DermataTherapeutics #Xyngari #FDAApproval #AcneTreatment #BiotechInnovation #Phase3ClinicalTrial #SkincareResearch #Humanteconomy #Humantec #KStrategyand
Dermata’s Xyngari(TM) Set to Transform Acne Treatment with FDA Approval
kstrategyand.com/pharma-news
#DermataTherapeutics #Xyngari #FDAApproval #AcneTreatment #BiotechInnovation #Phase3ClinicalTrial #SkincareResearch #Humanteconomy #Humantec #KStrategyand